Similarly in inflammatory bowel disease (IBD) patients, expression of other biomarkers like IL-1β, IL-10 and MMP-3 was dose-dependently inhibited (Gupta et al., 2013 ▶). This evidence concerns the gene IL10 and inflammatory bowel disease.